Sanjeev K. Mahanta
His practice is focused on assisting clients with identifying and procuring patent rights, and providing opinions (freedom to operate, invalidity), litigation support, and patent related transactional support such as reviewing agreements for IP licensing, Non-Disclosure agreements (NDAs), and agreements with contract research organizations (CROs).
Sanjeev has drafted and prosecuted patent applications in a wide variety of technology areas including biotechnology, microbiology, immunology, pharmaceuticals, chemistry, materials science, nanotechnology, drug delivery, personalized medicine, and diagnostics.
Prior to joining the law profession, Sanjeev was Director of Research in a Biotechnology company focused on developing cancer therapeutics. Previously, Sanjeev carried out postdoctoral research in molecular biology at Harvard University and at the New York University Medical Center. Sanjeev was previously an attorney at Posternak Blankstein & Lund LLP.
Publications, Presentations & Recognitions
“Simultaneous Invention as Secondary Evidence of Obviousness,” IP Watchdog (February 14, 2019)
Bar & Court Admissions
- Massachusetts Bar
New England LawJD,2011Indian Institute of SciencePhD,1992Guwahati UniversityBS,1983